Pharmaceutical Sterility Testing Industry

The global pharmaceutical sterility testing market was valued at approximately USD 1.59 billion in 2023, with projections indicating a compound annual growth rate (CAGR) of 11.02% from 2024 to 2030. This growth is primarily driven by several key factors, including increased government investments, robust research and development (R&D) activities, a rising number of drug launches, and an enhanced focus on quality and sterility in pharmaceutical products. The development of comprehensive sterility testing procedures is governed by stringent policies and quality control standards, ensuring that all processes meet the highest safety and efficacy benchmarks.

Government initiatives play a crucial role in shaping the healthcare landscape, providing vital financial support that significantly influences the advancement and implementation of modern sterility testing procedures within the pharmaceutical industry. This increased funding is particularly directed toward R&D efforts for novel therapeutics, including vaccines, biologics, and other sterile products, all of which require rigorous sterility testing to ensure their safety and effectiveness. As a result, the sterility testing market is witnessing the introduction of cutting-edge technologies and innovative solutions.

For example, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), total healthcare R&D expenditure in the European Union reached approximately USD 48.5 billion in 2022, up from USD 46.4 billion in 2021. This upward trend in investment highlights the growing commitment to advancing pharmaceutical research and the importance of stringent sterility testing protocols in the development of new healthcare products.

Gather more insights about the market drivers, restrains and growth of the Pharmaceutical Sterility Testing Market

Product Type Insights

In 2023, the kits & reagents segment led the market, capturing the largest revenue share at 60.30%.

• The market is divided into kits and reagents, instruments, and services, with kits & reagents holding the highest share.
• In the pharmaceuticals and medical devices sectors, a new, fresh kit is required for each sterility test, driving continuous demand for these products.
• Key factors contributing to the segment's growth include:
• Increasing use of kits & reagents for sterility testing
• Rising prevalence of diseases requiring advanced testing methods
• Growing investments in R&D for medical advancements
• Development of advanced and cost-effective technologies in testing solutions
• Expanding applications of sterility and molecular testing in various medical and pharmaceutical fields
• The global demand for new therapeutics is also expected to support further growth for this segment.

The services segment is projected to experience the fastest CAGR of 10.80% over the forecast period.

• This rapid growth is driven by factors such as:
• Increasing disease prevalence and the corresponding need for comprehensive testing services
• Rising R&D activities in the medical and pharmaceutical sectors
• Growing government investments aimed at enhancing healthcare infrastructure
• Expanding drug pipelines, with new products needing rigorous testing and quality assurance
• Heightened focus on quality and sterility in healthcare, ensuring safety and efficacy in therapeutic solutions

Order a free sample PDF of the Pharmaceutical Sterility Testing Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com/

Follow Us: LinkedIn | Twitter